- Home
- GEL vs HROW Comparison
GEL vs HROW Comparison
Compare GEL & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GEL | HROW |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 1996 | 2008 |
Fundamental Metrics
Financial Performance| Metric | GEL | HROW |
|---|---|---|
| Price | $13.60 | $30.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $18.33 | ★ $65.00 |
| AVG Volume (30 Days) | 257.2K | ★ 486.5K |
| Earning Date | 10-29-2026 | 11-09-2026 |
| Dividend Yield | ★ 5.81% | N/A |
| EPS Growth | N/A | ★ 71.43 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $2,912,770,000.00 | N/A |
| Revenue This Year | $9.79 | $28.81 |
| Revenue Next Year | N/A | $53.97 |
| P/E Ratio | $65.86 | ★ N/A |
| Revenue Growth | ★ 43.60 | N/A |
| 52 Week Low | $13.75 | $28.54 |
| 52 Week High | $18.64 | $54.98 |
Technical Indicators
Market Signals| Indicator | GEL | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 25.30 | 27.10 |
| Support Level | N/A | $28.54 |
| Resistance Level | $15.28 | $35.43 |
| Average True Range (ATR) | 0.40 | 1.25 |
| MACD | -0.17 | -0.21 |
| Stochastic Oscillator | 0.11 | 11.48 |
Price Performance
Historical ComparisonAbout GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.